BridgeMD
New treatment option for Prematurity
Official title Early Intervention Based on Neonatal Crawling in Very Premature Infants at Risk For Neurodevelopmental Disorder
ClinicalTrials.gov ID: NCT06027645
What this study is testing
- What it's testing
- Extreme prematurity is constantly increasing according to the World Health Organization. However, methods to train premature infants at risk of disability is sorely lacking.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 39 to 42
You may be able to join if
- Term between 24-26 GA or 26-32 GA with suspected brain lesion
- parental consent
- family living in intervention area
- good tolerance on the first crawliskate trial
You likely can't join if
- no bronchodysplasia defined by oxygen dependency after 36 GA
- no medical disease
- no limb deformity
- no karyotype anomaly
- no visual or auditory impairment
The study team makes the final eligibility decision.
Where it's taking place
- Paris, France
- Paris, Île-de-France Region, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 39 weeks to 42 weeks. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, France; Paris, Île-de-France Region, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.